iRadimed IRMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.82M+24.1% | $6.44M+25.2% | $5.58M+10.4% | $5.77M+17.8% | $4.69M+13.3% | ||
| $455K+135% | $380.68K+95.0% | $383.72K+94.2% | $207.6K+4.3% | $194K-14.2% | ||
| $684K-17.2% | $696.24K+6.1% | $666.08K+5.7% | $730.68K+20.0% | $826K+31.4% | ||
| $137K+205% | -$2.33M-2,294% | -$134.87K— | -$133.12K-108% | -$130K+85.8% | ||
| $40K+367% | -$875+75.7% | -$50.24K+54.3% | -$17.89K-132% | -$15K+60.7% | ||
| -$212K-110% | —— | $2.89M+270% | —— | $2.14M+179% | ||
| $534K+345% | $0+100% | $559.68K+180% | $751.23K+255% | $120K+229% | ||
| $362K-47.8% | -$513.07K-32.2% | $432.49K— | -$689.43K-463% | $694K+208% | ||
| -$1.15M+23.5% | -$853.42K-275% | $861.03K+127% | —— | -$1.51M-139% | ||
| -$21K+95.8% | $548.35K-2.9% | -$827.63K-1,089% | $917.28K+5,331% | -$506K-221% | ||
| $0+100% | —— | —— | —— | -$150K-500% | ||
| $305K-44.2% | $117.95K+334% | $141.84K+388% | $789.21K— | $547K+303% | ||
| $2.09M+258% | —— | —— | —— | $584K+397% | ||
| $8.29M+93.2% | $5.92M-1.1% | $6.99M-23.4% | $7.75M+16.7% | $4.29M+10.5% | ||
| $403K-89.1% | $294.17K-89.5% | $1.14M-70.1% | $2.64M+132% | $3.7M+1,266% | ||
| $66K-70.0% | —— | —— | —— | $220K— | ||
| -$469K+88.0% | -$416.41K+86.4% | -$1.26M+68.5% | -$2.82M-122% | -$3.92M-718% | ||
| $2.56M+18.2% | $8.55M+350% | $2.16M+13.8% | $2.16M+13.8% | $2.16M-72.9% | ||
| $50K-56.9% | $2.32M+328% | $29.56K+65.8% | $96.29K+50.6% | $116K+81.6% | ||
| -$2.61M-14.4% | -$10.87M-350% | -$2.19M-14.3% | -$2.26M-15.2% | -$2.28M+71.7% | ||
| $5.22M+374% | -$5.37M-1,146% | $3.53M+10.8% | $2.66M-21.8% | -$1.9M+58.9% | ||
| $14K+55.6% | $1.42M-30.8% | $153.72K-89.4% | $2.34M-17.1% | $9K-95.3% | ||
| $137K+205% | -$2.33M-2,294% | -$134.87K— | -$133.12K-108% | -$130K+85.8% | ||
| -$1.15M+23.5% | -$853.42K-275% | $861.03K+127% | —— | -$1.51M-139% | ||
| $0+100% | —— | —— | —— | -$150K-500% | ||
| -$13K-286% | $24.54K+72.4% | $9.88K— | $0-100% | $7K+115% | ||
| -$21K+95.8% | $548.35K-2.9% | -$827.63K-1,089% | $917.28K+5,331% | -$506K-221% | ||
| $14K— | $1.41M+617% | $1.37M+599% | -$206.6K-205% | $0-100% | ||
| $114K+21.3% | $16.79K— | —— | $67.65K+219% | $94K+182% | ||
| $15K+139% | $20.33K— | $19.15K-80.3% | $45.52K-30.7% | -$38K-197% | ||
| $40K+367% | -$875+75.7% | -$50.24K+54.3% | -$17.89K-132% | -$15K+60.7% | ||
| $66K-70.0% | —— | —— | —— | $220K— | ||
| $305K-44.2% | $117.95K+334% | $141.84K+388% | $789.21K— | $547K+303% | ||
| $14K+55.6% | $1.42M-30.8% | $153.72K-89.4% | $2.34M-17.1% | $9K-95.3% | ||
| $7.89M+1,226% | $5.63M+76.1% | $5.85M+10.2% | $5.11M-7.2% | $595K-83.5% | ||
| $7.89M+1,226% | $5.63M+76.1% | $5.85M+10.2% | $5.11M-7.2% | $595K-83.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does iRadimed generate?
- iRadimed (IRMD) generated $28.9M in operating cash flow over the trailing twelve months.
- What is iRadimed's free cash flow?
- After $4.5M of capital expenditures, iRadimed's free cash flow was $24.5M over the trailing twelve months, up 67.6% year over year.
- Where does iRadimed's cash flow data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
